At EuroMedLab 2023 in Rome, Roche has introduced the next generation of its serum work area, several molecular systems and the cobas connection module. Also on show is the new navify digital solution to help laboratories address their needs for digital infrastructure, operational excellence and medical insights.
Visitors to the Roche stand at the event can also experience an integrated laboratory that goes beyond simply connecting individual technologies to demonstrate true end-to-end operational excellence.
"With the ever-changing needs of the healthcare system, laboratories and clinicians are expected to optimise laboratory operations and efficiencies while improving patient care," said Ann Costello, Head of Roche Diagnostics Solutions at Roche Diagnostics. "We are pleased to present the next generation of innovative solutions that simplify and streamline testing for laboratories of all sizes, throughputs and disciplines, while supporting clinical decision-making to improve patient care."
Roche will be featuring new innovations, such as several molecular systems from the growing PCR portfolio – the cobas 5800 (pictured above) and the new LightCycler PRO System, launching later this year. A prototype for the new cobas Mass Spec system will be revealed, bringing mass spectrometry into the routine testing environment. The system will complement the serum work area portfolio so that in the future, healthcare communities will benefit from an extended diagnostic platform offering clinical chemistry, heterogeneous immunoassays, and mass spectrometry. The new cobas connection modules (CCM Vertical), a flexible modular system that uses lab space effectively, and seamlessly integrates into the existing cobas connection modules, improving laboratory efficiency, will also be featured.
